603676 卫信康
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)11.91716.71415.4699.3556.110
总资产报酬率 ROA (%)8.82112.43411.1966.7174.385
投入资产回报率 ROIC (%)11.52316.19215.1449.2585.908

边际利润分析
销售毛利率 (%)54.09750.81552.60251.58846.328
营业利润率 (%)22.74413.22811.6279.8968.284
息税前利润/营业总收入 (%)28.38915.99012.82111.0609.754
净利润/营业总收入 (%)25.81416.18112.6539.2798.164

收益指标分析
经营活动净收益/利润总额(%)66.36167.52391.57881.92953.177
价值变动净收益/利润总额(%)7.02011.3138.6409.91419.380
营业外收支净额/利润总额(%)20.59518.93810.83210.45614.847

偿债能力分析
流动比率 (X)2.8253.0392.7662.4072.426
速动比率 (X)2.7542.9422.6872.3532.368
资产负债率 (%)27.27724.56826.71028.63827.709
带息债务/全部投入资本 (%)0.2830.3040.2860.325--
股东权益/带息债务 (%)34,142.61231,837.47233,929.86730,373.846100,797.706
股东权益/负债合计 (%)266.605307.033274.389249.183260.900
利息保障倍数 (X)-112.020-48.724-58.8861,291.491370.569

营运能力分析
应收账款周转天数 (天)52.35854.17552.96773.3300.000
存货周转天数 (天)22.45819.61314.99415.9560.000